After 18 years of premiums, a widow assumes her long-term care policy will cover the aide her neighbor swears by. Then she ...

Lycia Therapeutics just put numbers on its Nasdaq debut: 14.7 million shares at $16 to $18, or about $250 million at the top.

Backlog hit a record $109.6 billion, and management answered by lifting the 2026 adjusted EPS midpoint to $29.35-$29.75.

AM ET, carrying a three-quarter beat streak into a quarter where eight analysts expect $1.075 in EPS on $496.23 million of ...

AM ET carrying a six-quarter beat streak, with consensus at $2.40 EPS. Card delinquencies and the revived late-fee rulemaking ...

AM ET, with analysts looking for $3.63 a share. The last four quarters all landed ahead of estimates, so anything short ...

AM ET with nine analysts looking for $0.96 EPS on $392.7 million in revenue. Three straight beats put the burden on net ...

Buying fine wine inside a self-directed IRA feels like smart diversification until the IRS steps in and turns the purchase ...

A Dallas woman thought her Texas address kept her completely clear of any tax bill after inheriting her father's Pennsylvania ...

Naming a trust as your IRA beneficiary sounds like a smart way to protect grandchildren from themselves, but the tax bracket ...

A January market crash cannot shrink your RMD, because the IRS locked that number in on December 31, but retirees who know ...

Traders poured tens of millions into a triple-leveraged biotech fund in a single day, a move that looks like bold conviction ...